Search Results

• • 8,121 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Select Pleural effusion during acute myeloid leukemia induction chemotherapy: a perplexing case

  1

  Pleural effusion during acute myeloid leukemia induction chemotherapy: a perplexing case

  Authors:Chandran Nair, Milind Kumar, and Sreejith OdayothFrom:Journal of Cancer Research and Therapeutics (Vol. 9, Issue 2) Peer-Reviewed

  April-June 20131,366 words Case study 1360LByline: Chandran. Nair, Milind. Kumar, Sreejith. Odayoth We are reporting a case of pneumonia associated with pleural effusion during the neutropenic phase of induction chemotherapy. In spite of being Adenosine...
• Select Significance of neuropilin-1 expression in acute myeloid leukemia / Ciddi, Direncli, Oldurucu, Kazanilmis Aplastik Aneminin Klinik Seyrine E Uygulamasinin Katkisi

  2

  Significance of neuropilin-1 expression in acute myeloid leukemia / Ciddi, Direncli, Oldurucu, Kazanilmis Aplastik Aneminin Klinik Seyrine E Uygulamasinin Katkisi

  Authors:Tarif H. Sallam, Manal A. Shams, Eldin El Telbany, Hanan M. Mahmoud, and Mutea A. IskanderFrom:Turkish Journal of Hematology (Vol. 30, Issue 3) Peer-Reviewed

  Sept. 20134,324 words Report 1530LAbstract: Objective: Neuropilin-1 is a vascular endothelial growth factor receptor that acts as a mediator of angiogenesis. Its importance in hematological malignancies such as acute myeloid leukemia (AML) remains to...
• Select The impact of FLT3 mutations on the development of acute myeloid leukemias

  3

  The impact of FLT3 mutations on the development of acute myeloid leukemias

  Authors:Ugo Testa and Elvira PelosiFrom:Leukemia Research and TreatmentPeer-Reviewed

  Annual 201312,218 words Report 1510LThe development of the genetic studies on acute myeloid leukemias (AMLs) has led to the identification of some recurrent genetic abnormalities. Their discovery was of fundamental importance not only for a better...
• Select Serum 25-hydroxyvitamin D levels in relation to disease status and prognosis in acute myeloid leukemia

  4

  Serum 25-hydroxyvitamin D levels in relation to disease status and prognosis in acute myeloid leukemia

  Authors:Tahani Elkerdany, Doaa Eissa, and Mohamed MoussaFrom:The Egyptian Journal of Haematology (Vol. 39, Issue 2) Peer-Reviewed

  April-June 20142,829 words Report 1630LByline: Tahani. Elkerdany, Doaa. Eissa, Mohamed. Moussa Background Low vitamin D levels are linked to higher incidence of cancer. Although vitamin D insufficiency is related to inferior prognosis in some cancers, no...
• Select Novel formulation of cytarabine and daunorubicin: A new hope in AML treatment

  5

  Novel formulation of cytarabine and daunorubicin: A new hope in AML treatment

  Author:Lalit RautFrom:South Asian Journal of Cancer (Vol. 4, Issue 1) Peer-Reviewed

  January-March 20152,563 words Report 1640LByline: Lalit. Raut Acute myeloid leukemia (AML) treatment has always been a challenge to the treating physician. Continuous efforts are being made to improve treatment outcomes in AML. CPX-351 is a pharmacologic...
• Select Therapy of older persons with acute myeloid leukemia

  6

  Therapy of older persons with acute myeloid leukemia

  Authors:R.P. Gale and A. HochhausFrom:Leukemia (Vol. 29, Issue 4) Peer-Reviewed

  Apr. 2015347 words Brief article, Clini... 1240LAbout one-half of persons with acute myeloid leukemia (AML) are more than 65 years of age and many are more than 75 years. As such, they pose a difficult therapy challenge. First, many of these persons are excluded from...
• Select Reports on Acute Promyelocytic Leukemia Findings from Tokyo University of Pharmacy and Life Sciences Provide New Insights (Delphinidin induces cytotoxicity and potentiates cytocidal effect in combination with arsenite in an acute promyelocytic ...)

  7

  Reports on Acute Promyelocytic Leukemia Findings from Tokyo University of Pharmacy and Life Sciences Provide New Insights (Delphinidin induces cytotoxicity and potentiates cytocidal effect in combination with arsenite in an acute promyelocytic ...)

  From:Obesity, Fitness & Wellness Week

  July 25, 2015444 words Article 1480L2015 JUL 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Oncology have been published. According to news reporting originating from Hachioji, Japan, by...
• Select Management of acute myeloid leukemia during pregnancy

  8

  Management of acute myeloid leukemia during pregnancy

  Authors:Irit Avivi and Benjamin BrennerFrom:Future Oncology (Vol. 10, Issue 8) Peer-Reviewed

  June 20147,069 words Report 2140LAuthor(s): Irit Avivi [*] aff1 aff2 , Benjamin Brenner aff1 aff2 KEYWORDS acute leukemia; fertility; pregnancy; treatment The incidence of acute leukemia (AL) occurring during gestation is estimated to be...
• Select Researchers at Taipei Medical University Report New Data on Acute Myeloid Leukemia (Identification of a potent 5-phenyl-thiazol-2-ylamine-based inhibitor of FLT3 with activity against drug resistance-conferring point mutations)

  9

  Researchers at Taipei Medical University Report New Data on Acute Myeloid Leukemia (Identification of a potent 5-phenyl-thiazol-2-ylamine-based inhibitor of FLT3 with activity against drug resistance-conferring point mutations)

  From:Obesity, Fitness & Wellness Week

  Aug. 15, 2015368 words Brief article 1430L2015 AUG 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Acute Myeloid Leukemia. According to news reporting out of Taipei, Taiwan, by...
• Select Preclinical study shows potential to increase the effectiveness of leukemia treatments

  10

  Preclinical study shows potential to increase the effectiveness of leukemia treatments

  From:Obesity, Fitness & Wellness Week

  Oct. 31, 2015466 words Article 1720L2015 OCT 31 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Preclinical experiments led by a team of researchers at VCU Massey Cancer Center have shown that blocking the...
• Select Findings from University of Bari in Acute Promyelocytic Leukemia Provides New Insights (Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia)

  11

  Findings from University of Bari in Acute Promyelocytic Leukemia Provides New Insights (Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia)

  From:Obesity, Fitness & Wellness Week

  Oct. 31, 2015372 words Brief article, Repor... 1780L2015 OCT 31 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on Leukemias is the subject of a report. According to news reporting originating from Bari, Italy, by...
• Select Etoposide/lomustine/temozolomide: acute myeloid leukaemia in a child: case report

  12

  Etoposide/lomustine/temozolomide: acute myeloid leukaemia in a child: case report

  From:Reactions Weekly (Issue 1336)

  Jan. 29, 2011293 words Brief article, Case ... 1170L[S] An approximately 10-year-old girl developed acute myeloid leukaemia (AML) following chemotherapy with etoposide, lomustine and temozolomide for a brain tumour [routes not stated]. The girl was diagnosed with a...
• Select Tretinoin: differentiation syndrome: case report

  13

  Tretinoin: differentiation syndrome: case report

  From:Reactions Weekly (Issue 1346)

  Apr. 9, 2011320 words Brief article, Case ... 890L[S] A 38-year-old man with acute promyelocytic leukaemia (APL) developed differentiation syndrome during treatment with tretinoin. The man started receiving tretinoin [all-trans retinoic acid; ATRA]...
• Select Pediatric acute myeloid leukemia

  14

  Pediatric acute myeloid leukemia

  Author:Gertjan JL KaspersFrom:Expert Review of Anticancer Therapy (Vol. 12, Issue 3) Peer-Reviewed

  Mar. 20127,387 words Report 1440LAuthor(s): Gertjan JL Kaspers 1 Keywords : allogeneic stem cell transplantation; childhood; children; clofarabine; gemtuzumab ozogamicin (Mylotarg® ); late effects; liposomal daunorubicin (DaunoXome® ); minimal...
• Select Idarubicin: congestive heart failure and ventricular tachycardia: case report

  15

  Idarubicin: congestive heart failure and ventricular tachycardia: case report

  From:Reactions Weekly (Issue 1307)

  June 26, 2010293 words Brief article, Case ... 1000L[S] A 34-year-old woman developed congestive heart failure and ventricular tachycardia after receiving induction chemotherapy including idarubicin for acute myeloid leukaemia. The woman received 30-minute IV...
• Select Doxorubicin/etoposide/ifosfamide: therapy-related acute myeloid leukaemia: case report

  16

  Doxorubicin/etoposide/ifosfamide: therapy-related acute myeloid leukaemia: case report

  From:Reactions Weekly (Issue 1287)

  Feb. 6, 2010329 words Brief article, Case ... [S] A 34-year-old woman developed therapy-related acute myeloid leukaemia (t-AML) as a consequence of a genetic mutation in the RUNX1/CBFB complex, after receiving treatment with doxorubicin, etoposide and ifosfamide...
• Select TLR9 but not NOD2/CARD15 gene polymorphism influenced outcome in AML-patients transplanted from HLA-identical sibling donors

  17

  TLR9 but not NOD2/CARD15 gene polymorphism influenced outcome in AML-patients transplanted from HLA-identical sibling donors

  Authors:A.H. Elmaagacli, M. Koldehoff, and D. BeelenFrom:Bone Marrow Transplantation (Vol. 43, Issue S1) Peer-Reviewed

  Mar. 2009430 words Author abstract, Bri... We evaluated in a homogenous group of 101 AML-patients after non-T-cell depleted, myeloablative transplantation from HLA-identical sibling donors the role of gene polymorphism of TLR9, IL23R, and NOD2 on the outcome of...
• Select Allogeneic transplantation from alternative donors is feasible in elderly patients with poor prognosis acute myeloid leukaemia or myelodysplastic syndrome: a single-centre experience

  18

  Allogeneic transplantation from alternative donors is feasible in elderly patients with poor prognosis acute myeloid leukaemia or myelodysplastic syndrome: a single-centre experience

  Authors:M. Tassara, M. Bernardi, J. Peccatori, A. Crotta, M.T. Lupo, C. Stanghellini, et al.From:Bone Marrow Transplantation (Vol. 43, Issue S1) Peer-Reviewed

  Mar. 2009434 words Author abstract, Bri... Background: allogeneic (allo) stem cell transplantation (SCT) is the only potentially curative strategy for poor prognosis acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS). Patients (pts) older than 60...
• Select Hypocellular acute myeloid leukemia with bone marrow necrosis in young patients: two case reports

  19

  Hypocellular acute myeloid leukemia with bone marrow necrosis in young patients: two case reports

  Authors:Deepali Jain, Tejinder Singh, and Naresh KumarFrom:Journal of Medical Case Reports (Vol. 3) Peer-Reviewed

  Jan. 26, 20091,851 words Case study Authors: Deepali Jain (corresponding author) [1]; Tejinder Singh [1]; Naresh Kumar [2] Introduction The infrequent occurrence of hypocellularity at presentation of acute leukemia has been widely recognized....
• Select Pharmacogenomics in acute myeloid leukemia

  20

  Pharmacogenomics in acute myeloid leukemia

  Authors:Christophe Roumier and Meyling H CheokFrom:Pharmacogenomics (Vol. 10, Issue 11) Peer-Reviewed

  Nov. 20099,510 words Report 1420LAuthor(s): Christophe Roumier 1 , Meyling H Cheok [[dagger]] 2 KEYWORDS: acute myeloid leukemia; pharmacogenetics; pharmacogenomics; treatment response The efficacy of antileukemic drugs is determined by the...